TherapeuticsMD, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TherapeuticsMD, Inc. stock issued during period, value, conversion of units for the quarter ending 2015-06-30 was $7.60K, a 91.26% decline year-over-year.
- TherapeuticsMD, Inc. stock issued during period, value, conversion of units for the quarter ending 2014-09-30 was $94.00K.
- TherapeuticsMD, Inc. stock issued during period, value, conversion of units for the quarter ending 2014-06-30 was $87.00K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2015-06-30 | $7.60K 10-Q · filed 2015-08-07 | |
| 2014-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2014-06-30 | $87.00K 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |